A Review of Severe Candida Infection in ICU Patients
Author Information
Author(s): Elnè Noppè, Julian Robert Paul Eloff, Sean Keane, Ignacio Martin-Loeches
Primary Institution: St James' Hospital, Dublin, Ireland
Hypothesis
What are the risk factors, diagnosis, and treatment challenges of invasive candidiasis in ICU patients?
Conclusion
Invasive candidiasis remains a significant challenge in ICUs due to rising incidence and mortality rates, complicated by changing fungal ecology and resistance.
Supporting Evidence
- Candida species are the most common cause of invasive fungal infections in critically ill patients.
- The incidence of invasive candidiasis in ICUs is significantly higher than in other hospital wards.
- Emerging multidrug-resistant strains complicate the diagnosis and treatment of invasive candidiasis.
Takeaway
Candida infections are serious fungal infections that can make ICU patients very sick. It's important to find and treat them quickly, but it's hard because the fungi are changing and some are becoming resistant to medicines.
Methodology
The review synthesizes findings from various studies and expert guidelines on invasive candidiasis in ICU settings.
Potential Biases
Most clinical trials focus on patients with candidemia, which may not represent the broader population of those with invasive candidiasis.
Limitations
The review highlights the lack of consistent terminology and denominators in studies, complicating the determination of incidence and prevalence.
Participant Demographics
The review discusses a diverse patient population in ICUs, including those with various risk factors for invasive candidiasis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website